|
April 2010
 Quanta
Biodesign and
Chemic Laboratories Inc.
formed a joint
cooperation agreement that enables the two pharmaceutical development and
manufacturing firms to cooperate on a variety of client engagements, primarily
in the areas of dPEG® cGMP manufacturing. Under this agreement,
the companies can now leverage their collective expertise in synthetic chemistry
and manufacturing offering our clients a stream lined process to move from
R&D materials needs (Preclinical through phase I) to cGMP material needs
(Phase II and beyond)
|
